Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04106219 |
Title | A Study of LY3295668 Erbumine in Participants With Relapsed/Refractory Neuroblastoma |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Eli Lilly and Company |
Indications | |
Therapies | |
Age Groups: | child | adult |
Covered Countries | USA | ITA | GBR | FRA | ESP | DEU | BEL | AUS |